Cell-type variation in stress responses as a consequence of manipulating GRP78 expression in neuroectodermal cells

Area of Science:

• Cellular biology
• Cancer research
• Molecular oncology

Background:

• Glucose-regulated protein 78 (GRP78) acts as a sensor for endoplasmic reticulum (ER) stress.
• The unfolded protein response (UPR) is activated by ER stress, involving key UPR activators.
• Differential roles of GRP78 in various neuroectodermal cancers are not well understood.

Purpose of the Study:

• To investigate the distinct functional roles of GRP78 in mediating ER stress effects.
• To compare GRP78's role in neuroblastoma versus other neuroectodermal tumors like melanoma and glioblastoma.
• To elucidate how GRP78 influences cancer cell sensitivity to ER stress.

Main Methods:

• Utilized knockdown and overexpression of GRP78 in neuroblastoma, melanoma, and glioblastoma cell lines.
• Assessed protein and transcript expression via Western blotting, confocal microscopy, and real-time PCR.
• Measured cellular stress (oxidative stress, ubiquitinated proteins) and response (apoptosis, viability).

Main Results:

• Neuroblastoma cells exhibited higher sensitivity to ER stress compared to melanoma and glioblastoma.
• GRP78 knockdown sensitized melanoma and glioblastoma cells but not neuroblastoma cells to ER stress.
• GRP78 overexpression decreased stress sensitivity in melanoma/glioblastoma but increased it in neuroblastoma, activating caspase-3-independent cell death and UPR activators like IRE1.

Conclusions:

• Cell-type specific differences in GRP78 function significantly impact ER stress sensitivity in neuroectodermal cancers.
• The interaction between GRP78 and UPR activators, particularly IRE1, dictates differential cancer cell responses to ER stress.
• Findings suggest GRP78 as a potential therapeutic target with context-dependent effects in neuroblastoma versus other neuroectodermal tumors.